Martin-Rendon E - Search Results

1

CXCR2 modulates bone marrow vascular repair and haematopoietic recovery post-transplant.

Hale SJ, Hale AB, Zhang Y, Sweeney D, Fisher N, van der Garde M, Grabowska R, Pepperell E, Channon K, Martin-Rendon E, Watt SM. Hale SJ, et al. Br J Haematol. 2015 May;169(4):552-64. doi: 10.1111/bjh.13335. Epub 2015 Mar 9. Br J Haematol. 2015. PMID: 25757087 Free PMC article.

2

Stem cell plasticity.

Martin-Rendon E, Watt SM. Martin-Rendon E, et al. Br J Haematol. 2003 Sep;122(6):877-91. doi: 10.1046/j.1365-2141.2003.04576.x. Br J Haematol. 2003. PMID: 12956757 Review. No abstract available.

3

Exploitation of stem cell plasticity.

Martin-Rendon E, Watt SM. Martin-Rendon E, et al. Transfus Med. 2003 Dec;13(6):325-49. doi: 10.1111/j.1365-3148.2003.00462.x. Transfus Med. 2003. PMID: 14651740 Review.

4

5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.

Martin-Rendon E, Sweeney D, Lu F, Girdlestone J, Navarrete C, Watt SM. Martin-Rendon E, et al. Vox Sang. 2008 Aug;95(2):137-48. doi: 10.1111/j.1423-0410.2008.01076.x. Epub 2008 Jun 28. Vox Sang. 2008. PMID: 18557828

5

Stem cell-related therapies for vascular diseases.

Martin-Rendon E, Snowden JA, Watt SM. Martin-Rendon E, et al. Transfus Med. 2009 Aug;19(4):159-71. doi: 10.1111/j.1365-3148.2009.00926.x. Transfus Med. 2009. PMID: 19706133 Review.

6

Transcriptional profiling of human cord blood CD133+ and cultured bone marrow mesenchymal stem cells in response to hypoxia.

Martin-Rendon E, Hale SJ, Ryan D, Baban D, Forde SP, Roubelakis M, Sweeney D, Moukayed M, Harris AL, Davies K, Watt SM. Martin-Rendon E, et al. Stem Cells. 2007 Apr;25(4):1003-12. doi: 10.1634/stemcells.2006-0398. Epub 2006 Dec 21. Stem Cells. 2007. PMID: 17185612

7

Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review.

Martin-Rendon E, Brunskill SJ, Hyde CJ, Stanworth SJ, Mathur A, Watt SM. Martin-Rendon E, et al. Eur Heart J. 2008 Aug;29(15):1807-18. doi: 10.1093/eurheartj/ehn220. Epub 2008 Jun 3. Eur Heart J. 2008. PMID: 18523058

8

Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease.

Brunskill SJ, Hyde CJ, Doree CJ, Watt SM, Martin-Rendon E. Brunskill SJ, et al. Eur J Heart Fail. 2009 Sep;11(9):887-96. doi: 10.1093/eurjhf/hfp101. Epub 2009 Aug 4. Eur J Heart Fail. 2009. PMID: 19654139 Free article.

9

Long-term effects of autologous bone marrow stem cell treatment in acute myocardial infarction: factors that may influence outcomes.

Clifford DM, Fisher SA, Brunskill SJ, Doree C, Mathur A, Clarke MJ, Watt SM, Martin-Rendon E. Clifford DM, et al. PLoS One. 2012;7(5):e37373. doi: 10.1371/journal.pone.0037373. Epub 2012 May 24. PLoS One. 2012. PMID: 22655042 Free PMC article.

10

Junctional Adhesion Molecule-A Is Highly Expressed on Human Hematopoietic Repopulating Cells and Associates with the Key Hematopoietic Chemokine Receptor CXCR4.

Chang CH, Hale SJ, Cox CV, Blair A, Kronsteiner B, Grabowska R, Zhang Y, Cook D, Khoo CP, Schrader JB, Kabuga SB, Martin-Rendon E, Watt SM. Chang CH, et al. Stem Cells. 2016 Jun;34(6):1664-78. doi: 10.1002/stem.2340. Epub 2016 Mar 15. Stem Cells. 2016. PMID: 26866290

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters